Emerging research links aging oral microbiome with senescent cells to amplify systemic inflammation, driving diseases like Alzheimer’s and offering new intervention targets such as probiotics an...
Recent studies show targeted epigenetic reprogramming with Yamanaka factors rejuvenates neurons, reversing cognitive decline in aged mice and reducing Alzheimer’s markers, with AI enhancing safe...
Recent studies reveal elevated IL-6 levels strongly correlate with Alzheimer’s and mild cognitive impairment, highlighting inflammaging’s role and potential for lifestyle and drug interven...
New research identifies IRF7 as a critical driver of unstable atherosclerotic plaques, offering a potential therapeutic target to reduce cardiovascular events through innovative clinical trials and te...
The rising popularity of plant-based diets is backed by scientific evidence showing reduced chronic disease risks and environmental benefits, with practical tips for integration. Plant-based diets are...
Recent studies show that targeting engrams with partial reprogramming factors improves memory in mouse models, offering a potential therapy for Alzheimer’s and age-related cognitive decline. New...
Recent studies reveal CAR-T cells with lecanemab antibodies reduce amyloid plaques in mice, highlighting a shift towards personalized cell-based therapies for Alzheimer’s treatment. New research...
A 2024 study in Nature Aging shows transferring young gut bacteria to aged mice rejuvenates intestinal stem cells via Wnt signaling, suggesting FMT’s potential for age-related disorders. Recent ...
Plant-based diets are surging globally, with studies showing up to 25% lower heart disease risk and 30% reduced emissions, driven by health and sustainability trends. The rise of plant-based diets is ...
A Nature Aging study shows mitochondrial stress enhances senolytic drugs like navitoclax, improving senescent cell removal by 40% with metabolic interventions. New research reveals mitochondrial stres...
